Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Chu

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignanciesJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2020
[Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018]S G Li, K Liao, D H Su, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|September 7, 2022
[Phacoemulsification combined with goniosynechialysis under a gonioscope in the treatment of angle-closure glaucoma: the effect of reopening the synechial anterior chamber angle]Y H Tang, Y Y Li, Y Q Xie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patientsJ Y Wong, D Z Chu, D Yamauchi, et al.
Neuropsychology|July 2, 2008
Effects of traumatic brain injury on working memory-related brain activation in adolescentsMary R Newsome, Joel L Steinberg, Randall S Scheibel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancerJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancerJeffrey Y C Wong, Stephen Shibata, Lawrence E Williams, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 20, 2016
Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in ChinaX Fan, M Xiao, S Chen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 23, 2016
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014F-P Hu, Y Guo, D-M Zhu, et al.
Physical Review Letters|November 5, 2023
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.20 ppmD P Aguillard, T Albahri, D Allspach, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignanciesJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2020
[Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018]S G Li, K Liao, D H Su, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|September 7, 2022
[Phacoemulsification combined with goniosynechialysis under a gonioscope in the treatment of angle-closure glaucoma: the effect of reopening the synechial anterior chamber angle]Y H Tang, Y Y Li, Y Q Xie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patientsJ Y Wong, D Z Chu, D Yamauchi, et al.
Neuropsychology|July 2, 2008
Effects of traumatic brain injury on working memory-related brain activation in adolescentsMary R Newsome, Joel L Steinberg, Randall S Scheibel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancerJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancerJeffrey Y C Wong, Stephen Shibata, Lawrence E Williams, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 20, 2016
Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in ChinaX Fan, M Xiao, S Chen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 23, 2016
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014F-P Hu, Y Guo, D-M Zhu, et al.
Physical Review Letters|November 5, 2023
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.20 ppmD P Aguillard, T Albahri, D Allspach, et al.
Pageof 10